Form 4 for NVAX NOVAVAX INC
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001104659-24-031167 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-05 | 2024-03-01 | NVAX | O'Hara Elaine | EVP, Chief Strategy Off | M - OptEx | $5.39 | +19.6K | 19.6K | New | +$105.6K |
| D | 2024-03-05 | 2024-03-01 | NVAX | O'Hara Elaine | EVP, Chief Strategy Off | F - Tax | $5.39 | -5,375 | 14.2K | -27% | -$29.0K |
| D | 2024-03-05 | 2024-03-01 | NVAX | O'Hara Elaine | EVP, Chief Strategy Off | M - OptEx | $0.00 | -19.6K | 39.2K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-01 | M | A | 19,600 | $5.39 | 19,600 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-01 | F | D | 5,375 | $5.39 | 14,225 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2024-03-01 | M | D | 19,600 | $0.00 | 39,200 | D | — · — to — | 19,600 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock. (F2) The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date. |